<HTML>
<HEAD>
<TITLE>sv8</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">As
filed with the Securities and Exchange Commission on June&nbsp;22, 2010
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 8pt">Registration No.&nbsp;333-_____
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 4pt">&nbsp;
</DIV>


<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>




<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>WASHINGTON, D.C. 20549</B>
</DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>FORM S-8</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>REGISTRATION OF SECURITIES UNDER<BR>
THE SECURITIES ACT OF 1933</B>
</DIV>

<DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B>WRIGHT MEDICAL GROUP, INC.</B>
</DIV>

<DIV align="center" style="font-size: 10pt">(Exact name of registrant as specified in its charter)</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="47%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Delaware</B><BR>
(State or other jurisdiction <BR>
of incorporation or organization)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>13-4088127</B><BR>
(I.R.S. Employer<BR>
Identification No.)</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><B>5677 Airline Road <BR>
Arlington, Tennessee</B><BR>
(Address of Principal Executive Offices)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>38002</B><BR>
(Zip Code)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Wright Medical Group, Inc.<BR>
Amended and Restated 2009 Equity Incentive Plan</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>and</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Inducement Stock Option Award</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">(Full title of the plan)
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><DIV style="width: 100%; border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Gary D. Henley<BR>
President and Chief Executive Officer<BR>
Wright Medical Group, Inc.<BR>
5677 Airline Road<BR>
Arlington, Tennessee 38002</B><BR>
(Name and address of agent for service)
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><DIV style="width: 100%; border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>(901)&nbsp;867-9971</B><BR>
(Telephone number, including area code, of agent for service)
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><DIV style="width: 100%; border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">Copy to:<BR>
Beverly Sanders Gates<BR>
Baker, Donelson, Bearman, Caldwell &#038; Berkowitz, PC<BR>
165 Madison Avenue, 20th Floor<BR>
Memphis, Tennessee 38103<BR>
(901)&nbsp;526-2000
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><DIV style="width: 100%; border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated
filer, a non-accelerated filer, or a smaller reporting company. See the definitions of &#147;large
accelerated filer,&#148; &#147;accelerated filer&#148; and &#147;smaller reporting company&#148; in Rule&nbsp;12b-2 of the
Exchange Act.
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="48%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="47%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Large accelerated filer <FONT face="Wingdings">&#120;</FONT>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Accelerated filer <FONT face="Wingdings">&#111;</FONT></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Non-accelerated filer <FONT face="Wingdings">&#111;</FONT>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Smaller reporting company <FONT face="Wingdings">&#111;</FONT></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">CALCULATION OF REGISTRATION FEE
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="20%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Proposed</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Proposed</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Amount</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Maximum</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Maximum</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Amount of</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Title of Securities</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">to be</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Offering Price</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Aggregate</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Registration</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">to be Registered</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">Registered<SUP style="font-size: 85%; vertical-align: text-top">(1)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">Per Share</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">Offering Price</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">Fee</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD nowrap valign="top">&nbsp;</TD>
</TR>


<TR valign="bottom" style="background: #cceeff">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Common Stock
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">700,000</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">$18.03 <SUP style="font-size: 85%; vertical-align: text-top">(2)</SUP>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">$12,621,000 <SUP style="font-size: 85%; vertical-align: text-top">(2)</SUP>
</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="center" valign="top">$900</TD>

</TR>

<TR valign="bottom">
    <TD nowrap valign="top">&nbsp;</TD>
</TR>


<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Common Stock
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">65,000</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">$16.43<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">$1,067,950 <SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="center" valign="top">$77</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">1.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>This Registration Statement covers 700,000 shares of common stock, $0.01 par value per
share (the &#147;Common Stock&#148;), of Wright Medical Group, Inc. issuable pursuant to the Wright
Medical Group, Inc. Amended and Restated 2009 Equity Incentive Plan (the &#147;Plan&#148;). The Plan
was amended and restated effective May&nbsp;13, 2010 upon the approval of the Registrant&#146;s
stockholders to increase by 700,000 the number of shares of Common Stock available for
awards under the Plan. Under the Plan as amended and restated, the Registrant is authorized
to issue 1,450,000 shares of Common Stock plus the number of shares of Common Stock granted
under the Wright Medical Group, Inc. Fifth Amended and Restated 1999 Equity Incentive Plan,
as amended (the &#147;1999 Equity Incentive Plan&#148;) that are not exercised or forfeited, lapsed
or expired, or otherwise terminate without delivery of any shares of any Common Stock
subject thereto, to the extent such Common Stock would otherwise again have been available
for issuance under the 1999 Equity Incentive Plan. In addition, this Registration Statement
includes 65,000 shares reserved for issuance pursuant to an Inducement Stock Option Grant
Agreement dated May&nbsp;31, 2010 between the Registrant and Raymond C. Kolls, Senior Vice
President, General Counsel and Secretary, approved by the Compensation Committee of the
Board of Directors of the Registrant. In addition, this Registration Statement covers such
indeterminable number of additional shares of Common Stock as may hereafter be offered or
issued pursuant to the Plan and the Inducement Stock Option Grant Agreement to prevent
dilution resulting from stock splits or similar transactions effected without receipt of
consideration and pursuant to Rule 416(c) under the Securities Act of 1933, as amended (the
&#147;Securities Act&#148;).</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">2.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>These figures are estimated solely for the purpose of calculating the amount of the
registration fee. The registration fee has been calculated pursuant to paragraphs (c)&nbsp;and
(h)&nbsp;of Rule&nbsp;457 under the Securities Act based upon the average of the high and low sales
prices of the Common Stock as reported by the Nasdaq Global Select
Market on June&nbsp;18, 2010.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">3.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>These figures are estimated solely for the purpose of calculating the amount of the
registration fee. The registration fee has been calculated pursuant to paragraph (h)&nbsp;of
Rule&nbsp;457 under the Securities Act based upon the price at which the options subject to the
Inducement Stock Option Grant Agreement may be exercised. The exercise price represents the
closing sale price of the Common Stock as reported by the Nasdaq Global Select Market on
May&nbsp;28, 2010, the date prior to the grant.</TD>
</TR>

</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>


<DIV style="font-family: 'Times New Roman',Times,serif">


<!-- TOC -->
<A name="toc"><DIV align="CENTER" style="page-break-before:always"><U><B>TABLE OF CONTENTS</B></U></DIV></A>

<P><CENTER>
<TABLE border="0" width="90%" cellpadding="0" cellspacing="0">
<TR>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="76%"></TD>
</TR>
<TR><TD colspan="9"><A HREF="#000">EXPLANATORY NOTE</A></TD></TR>
<TR><TD colspan="9"><A HREF="#001">PART I</A></TD></TR>
<TR><TD colspan="9"><A HREF="#002">PART II INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#003">Item 3. Incorporation of Documents by Reference</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#004">Item 4. Description of Securities</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#005">Item 5. Interests of Named Experts and Counsel</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#006">Item 6. Indemnification of Directors and Officers</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#007">Item 7. Exemption from Registration Claimed</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#008">Item 8. Exhibits</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#009">Item 9. Undertakings</A></TD></TR>
<TR><TD colspan="9"><A HREF="#010">SIGNATURES</A></TD></TR>
<TR><TD colspan="9"><A HREF="#011">INDEX TO EXHIBITS</A></TD></TR>
<TR><TD colspan="9"><A HREF="g23815exv4w4.htm">EX-4.4</A></TD></TR>
<TR><TD colspan="9"><A HREF="g23815exv5.htm">EX-5</A></TD></TR>
<TR><TD colspan="9"><A HREF="g23815exv23w1.htm">EX-23.1</A></TD></TR>
</TABLE>
</CENTER>
<!-- /TOC -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<!-- link1 "EXPLANATORY NOTE" -->
<DIV align="left"><A NAME="000"></A></DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>EXPLANATORY NOTE</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Pursuant to General Instruction E to Form S-8 under the Securities Act of 1933, as amended, with
respect to the registration of additional securities of the same class as other securities for
which registration statements on Form S-8 relating to the same employee benefit plans are
effective, Wright Medical Group, Inc. (the &#147;Registrant&#148;) hereby incorporates herein the contents of
its earlier registration statement, including any amendments thereto (Registration No.&nbsp;333-159227),
by this reference and hereby deems such contents to be a part hereof, except as otherwise updated
or modified in this filing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">This Registration Statement covers 700,000 additional shares of common stock, $0.01 par value per
share (the &#147;Common Stock&#148;), of the Registrant issuable pursuant to the Wright Medical Group, Inc.
Amended and Restated 2009 Equity Incentive Plan (the &#147;Plan&#148;). The Plan was amended and restated
effective May&nbsp;13, 2010 upon the approval of the Registrant&#146;s stockholders to increase by 700,000
the number of shares of Common Stock available for awards under the Plan. The Plan was originally
approved by the Registrant&#146;s stockholders May&nbsp;13, 2009. Prior to amending and restating the Plan,
the Registrant was authorized to grant equity based awards under the Plan for up to 750,000 shares
of Common Stock, plus the number of shares of Common Stock granted under the Wright Medical Group,
Inc. Fifth Amended and Restated 1999 Equity Incentive Plan, as amended (the &#147;1999 Equity Incentive
Plan&#148;) that are not exercised or forfeited, lapsed or expired, or otherwise terminate without
delivery of any shares of any Common Stock subject thereto, to the extent such Common Stock would
otherwise again have been available for issuance under the 1999 Equity Incentive Plan.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In addition, this Registration Statement covers 65,000 shares of Common Stock issuable pursuant to
an Inducement Stock Option Grant Agreement effective May&nbsp;31, 2010 between the Registrant and
Raymond C. Kolls, Senior Vice President, General Counsel and Secretary.
</DIV>

<!-- link1 "PART I" -->
<DIV align="left"><A NAME="001"></A></DIV>
<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>PART I</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The documents containing the information specified in Part&nbsp;I on Form S-8 will be sent or given to
participants as specified in Rule&nbsp;428(b)(1) of the Securities Act. Such documents are not required
to be, and are not, filed with the Securities and Exchange Commission (the &#147;Commission&#148;) either as
part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule
424 of the Securities Act. These documents and the documents incorporated by reference into this
Registration Statement pursuant to Item&nbsp;3 of Part&nbsp;II of this Registration Statement, taken
together, constitute a prospectus that meets the requirements of Section 10(a) of the Securities
Act.
</DIV>


<!-- link1 "PART II INFORMATION REQUIRED IN THE REGISTRATION STATEMENT" -->
<DIV align="left"><A NAME="002"></A></DIV>
<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>PART II<BR>
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B>
</DIV>



<!-- link2 "Item 3. Incorporation of Documents by Reference" -->
<DIV align="left"><A NAME="003"></A></DIV>
<DIV align="left" style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left"><B>Item&nbsp;3.</B></TD>
    <TD>&nbsp;</TD>
    <TD><B>Incorporation of Documents by Reference.</B></TD>
</TR>
</TABLE>
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The following documents filed by the Registrant with the Commission are incorporated by reference
into this Registration Statement:
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">1.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Annual report on Form 10-K for the year ended December&nbsp;31, 2009, filed on February&nbsp;22, 2010;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">2.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Current report on Form 8-K filed on March&nbsp;9, 2010;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">3.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Current report on Form 8-K filed on March&nbsp;25, 2010;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">4.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Quarterly report on Form 10-Q for the quarter ended March&nbsp;31, 2010, filed on May&nbsp;5, 2010;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">5.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Current report on Form 8-K filed on May&nbsp;5, 2010;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">6.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Current report on Form 8-K filed on May&nbsp;18, 2010;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">7.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Current report on Form 8-K filed on June&nbsp;1, 2010;</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->1<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">


<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">8.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The description of the Common Stock is set forth under the heading &#147;Type of Equity-Based
Awards&#148; in the Prospectus portion of Amendment No.&nbsp;2 to the Registration Statement on Form S-1
(Registration No.&nbsp;333-81618) filed with the Commission on February&nbsp;28, 2002.</TD>
</TR>

</TABLE>
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">All documents subsequently filed by the Registrant with the Commission pursuant to Sections&nbsp;13(a),
13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), prior
to the filing of a post-effective amendment which indicates that all the securities offered hereby
have been sold or which deregisters all securities then remaining unsold, shall be deemed to be
incorporated by reference in this Registration Statement and to be a part hereof from the date of
the filing of such documents with the Commission.
</DIV>


<!-- link2 "Item 4. Description of Securities" -->
<DIV align="left"><A NAME="004"></A></DIV>
<DIV align="left" style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left"><B>Item&nbsp;4.</B></TD>
    <TD>&nbsp;</TD>
    <TD><B>Description of Securities.</B></TD>
</TR>
</TABLE>
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Not applicable.
</DIV>


<!-- link2 "Item 5. Interests of Named Experts and Counsel" -->
<DIV align="left"><A NAME="005"></A></DIV>
<DIV align="left" style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left"><B>Item&nbsp;5.</B></TD>
    <TD>&nbsp;</TD>
    <TD><B>Interests of Named Experts and Counsel.</B></TD>
</TR>
</TABLE>
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Not applicable.
</DIV>



<!-- link2 "Item 6. Indemnification of Directors and Officers" -->
<DIV align="left"><A NAME="006"></A></DIV>
<DIV align="left" style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left"><B>Item&nbsp;6.</B></TD>
    <TD>&nbsp;</TD>
    <TD><B>Indemnification of Directors and Officers.</B></TD>
</TR>
</TABLE>
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;145 of the General Corporation Law of the State of Delaware (&#147;GCL&#148;) provides for the
indemnification of officers and directors under certain circumstances against expenses incurred in
successfully defending against a claim and authorizes Delaware corporations to indemnify their
officers and directors under certain circumstances against expenses and liabilities incurred in
legal proceedings involving such persons because of their being or having been an officer or
director.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;102(b) of the GCL permits a corporation, by so providing in its certificate of
incorporation, to eliminate or limit a director&#146;s liability to the corporation and its stockholders
for monetary damages arising out of certain alleged breaches of their fiduciary duty. Section
102(b)(7) of the GCL provides that no such limitation of liability may affect a director&#146;s
liability with respect to any of the following: (i)&nbsp;breaches of the director&#146;s duty of loyalty to
the corporation or its stockholders; (ii)&nbsp;acts or omissions not made in good faith or which involve
intentional misconduct of knowing violations of law; (iii)&nbsp;liability for dividends paid or stock
repurchased or redeemed in violation of the GCL; or (iv)&nbsp;any transaction from which the director
derived an improper personal benefit. Section&nbsp;102(b)(7) does not authorize any limitation on the
ability of the corporation or its stockholders to obtain injunctive relief, specific performance or
other equitable relief against directors.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Registrant&#146;s Fourth Amended and Restated Certificate of Incorporation, as amended, provides
that the Registrant shall indemnify to the fullest extent authorized or permitted under and in
accordance with the laws of the State of Delaware any person who was or is a party or is threatened
to be made a party to any action, whether civil, criminal, administrative or investigative by
reason of the fact that he or she is or was a director, officer, or employee or agent of the
Registrant, or is or was serving at the request of the Registrant in a similar capacity or in any
other capacity with another corporation, partnership, joint venture, trust or other enterprise,
against expenses (including attorneys&#146; fees), judgments, fines and amounts paid in settlement
actually and reasonably incurred by him or her in connection with such action if he or she acted in
good faith and in a manner he or she reasonably believed to be in or not opposed to the best
interests of the Registrant, and had no reasonable cause to believe his or her conduct was
unlawful. However, each director will continue to be subject to liability for any breach of the
director&#146;s duty of loyalty to the Registrant or the Registrant&#146;s stockholders and for acts or
omissions not in good faith or involving intentional misconduct or knowing violations of law or, if
in failing to act, the director shall have acted in a manner involving intentional misconduct or a
knowing violation of the law, or for any transaction in which the director derived an improper
personal benefit. Expenses incurred in defending a civil or criminal action shall (in the case of
any action involving a director of the Registrant) or may (in the case of any action involving an
officer, trustee, employee or agent) be paid by the Registrant in advance of the final disposition
of such action as authorized by the board of directors upon receipt of an undertaking by or on
behalf of the indemnified person to repay such amount if it shall ultimately be determined that he
or she is not entitled to be indemnified by the Registrant.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Registrant&#146;s Second Amended and Restated Bylaws provide that the Registrant will indemnify any
and all of the Registrant&#146;s directors and officers, including former directors and officers,
including those serving as officer or director of any corporation at the request of the Registrant,
to the fullest extent permitted under and in accordance with the laws of the State of Delaware.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Registrant has entered into an indemnification agreement with each of its directors and
officers that provides for the indemnification of such director or officer to the fullest extent
permitted by law for certain liabilities that arise by reason of the indemnitee&#146;s status as a
director, officer, employee, or agent of the Registrant or its affiliates. The indemnification
agreement provides that an indemnitee may be entitled to advancement of the expenses related to an
indemnifiable event and that the Registrant will cause the indemnitee to be covered by its general
liability insurance policy if the Registrant maintains such a policy. The rights of the indemnitee
under the indemnification agreement are in addition to any other rights that indemnitee may have
under the GCL, the Registrant&#146;s Fourth Amended and Restated Certificate of Incorporation, as
amended, and the Registrant&#146;s Second Amended and Restated Bylaws.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Registrant maintains a general liability insurance policy that covers certain liabilities of
directors and officers of the Registrant and its affiliates arising out of claims based on acts or
omissions in their capacities as directors or officers.
</DIV>


<!-- link2 "Item 7. Exemption from Registration Claimed" -->
<DIV align="left"><A NAME="007"></A></DIV>
<DIV align="left" style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left"><B>Item&nbsp;7.</B></TD>
    <TD>&nbsp;</TD>
    <TD><B>Exemption from Registration Claimed.</B></TD>
</TR>
</TABLE>
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Not applicable.
</DIV>


<!-- link2 "Item 8. Exhibits" -->
<DIV align="left"><A NAME="008"></A></DIV>
<DIV align="left" style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left"><B>Item&nbsp;8.</B></TD>
    <TD>&nbsp;</TD>
    <TD><B>Exhibits.</B></TD>
</TR>
</TABLE>
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The following exhibits are filed as part of this Registration Statement:
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="95%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="90%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Exhibit No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Description of Exhibits</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Fourth Amended and Restated Certificate of Incorporation of Wright Medical Group,
Inc., <SUP style="font-size: 85%; vertical-align: text-top">(1)</SUP> as amended by Certificate of Amendment of Fourth Amended and
Restated Certificate of Incorporation of Wright Medical Group, Inc.<SUP style="font-size: 85%; vertical-align: text-top">(2)</SUP></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Second Amended and Restated Bylaws of Wright Medical Group, Inc. <SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.3
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amended and Restated 2009 Equity Incentive Plan.<SUP style="font-size: 85%; vertical-align: text-top"> (4)</SUP></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.4*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Inducement Stock Option Grant Agreement between the Registrant and Raymond C. Kolls
dated May&nbsp;31, 2010.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">5*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Opinion of Baker, Donelson, Bearman, Caldwell &#038; Berkowitz, PC concerning the legality
of the securities being registered.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.1*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of KPMG LLP.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.2*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Baker, Donelson, Bearman, Caldwell &#038; Berkowitz, PC (included in Exhibit&nbsp;5).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">24*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Power of Attorney (reference is made to the signature page).</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<DIV align="left">
<DIV style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96"></TD>
</TR>

<TR valign="top">
    <TD nowrap align="left">*</TD>
    <TD>&nbsp;</TD>
    <TD>Filed herewith.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left"><SUP style="font-size: 85%; vertical-align: text-top">(1)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD>Incorporated by reference to the Registrant&#146;s Registration Statement on Form S-1
(Registration No.&nbsp;333-59732), as amended.</TD>
</TR>

</TABLE>


<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">





<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96"></TD>
</TR>

<TR valign="top">
    <TD nowrap align="left"><SUP style="font-size: 85%; vertical-align: text-top">(2)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD>Incorporated by reference to the Registrant&#146;s Registration Statement on Form S-8
filed on May&nbsp;14, 2004.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left"><SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD>Incorporated by reference to the Registrant&#146;s current report on Form 8-K filed on
February&nbsp;19, 2008.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left"><SUP style="font-size: 85%; vertical-align: text-top">(4)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD>Incorporated by reference to the Registrant&#146;s Definitive Proxy Statement filed on
April&nbsp;15, 2010.</TD>
</TR>

</TABLE>



<!-- link2 "Item 9. Undertakings" -->
<DIV align="left"><A NAME="009"></A></DIV>

<DIV align="left" style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left"><B>Item&nbsp;9.</B></TD>
    <TD>&nbsp;</TD>
    <TD><B>Undertakings.</B></TD>
</TR>
</TABLE>
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">(a)&nbsp;The undersigned Registrant hereby undertakes:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;To file, during any period in which offers or sales are being made, a post-effective
amendment to this Registration Statement:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) To include any prospectus required by Section&nbsp;10(a)(3) of the Securities Act;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) To reflect in the prospectus any facts or events arising after the effective date
of this Registration Statement (or the most recent post-effective amendment thereof) which,
individually or in the aggregate, represent a fundamental change in the information set
forth in this Registration Statement. Notwithstanding the foregoing, any increase or
decrease in volume of securities offered (if the total dollar value of securities offered
would not exceed that which was registered) and any deviation from the low or high end of
the estimated maximum offering range may be reflected in the form of prospectus filed with
the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price
represent no more than 20&nbsp;percent change in the maximum aggregate offering price set forth
in the &#147;Calculation of Registration Fee&#148; table in the effective Registration Statement; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) To include any material information with respect to the plan of distribution not
previously disclosed in this Registration Statement or any material change to such
information in the Registration Statement.
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information
required to be included in a post-effective amendment by those paragraphs is contained in periodic
reports filed with or furnished to the Commission by the Registrant pursuant to Section&nbsp;13 or
Section 15(d) of the Exchange Act that are incorporated by reference in this Registration
Statement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;That, for the purpose of determining any liability under the Securities Act, each such
post-effective amendment shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;To remove from registration by means of a post-effective amendment any of the securities
being registered which remain unsold at the termination of the offering.
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The undersigned Registrant hereby undertakes that, for purposes of determining any liability under
the Securities Act, each filing of the Registrant&#146;s annual report pursuant to Section 13(a) or
Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan&#146;s
annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in
this Registration Statement shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to
directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions,
or otherwise, the Registrant has been advised that in the opinion of the Commission such
indemnification is against public policy as expressed in the Securities Act and is, therefore,
unenforceable. In the event that a claim for indemnification against such liabilities (other than
the payment by the Registrant of expenses incurred or paid by a director, officer, or controlling
person of the Registrant in the successful defense of any action, suit or proceeding) is asserted
by such director, officer or controlling person in connection with the securities being registered,
the Registrant will, unless in the opinion of its counsel the matter has been settled by
controlling precedent, submit to a court of appropriate jurisdiction the
question whether such indemnification by it is against public policy as expressed in the Securities
Act and will be governed by the final adjudication of such issue.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->4<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- link1 "SIGNATURES" -->
<DIV align="left"><A NAME="010"></A></DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SIGNATURES</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has
reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has
duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of Arlington, State of Tennessee, on
June&nbsp;22, 2010.
</DIV>


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">WRIGHT MEDICAL GROUP, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Gary D. Henley
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Gary D. Henley&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">President and Chief Executive Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>POWER OF ATTORNEY</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Each of the undersigned directors and officers of Wright Medical Group, Inc. hereby severally
constitutes and appoints Raymond C. Kolls and Lance A. Berry, and each of them, as the
attorneys-in-fact for the undersigned, in any and all capacities, with full power of substitution,
to sign any and all pre- or post-effective amendments to this Registration Statement, any
subsequent registration statement for the same offering which may be filed pursuant to Rule 462(b)
under the Securities Act of 1933, as amended, and any and all pre- or post-effective amendments
thereto, and to file the same with exhibits thereto and other documents in connection therewith,
with the Securities and Exchange Commission, granting unto said attorneys-in-fact full power and
authority to do and perform each and every act and thing requisite and necessary to be done in and
about the premises, as fully to all intents and purposes as he might or could do in person, hereby
ratifying and confirming all that said attorney-in-fact may lawfully do or cause to be done by
virtue hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement
has been signed by the following persons in the capacities and on the dates indicated:
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="40%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">Signature</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">Title</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">Date</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD>&nbsp;</TD>
</TR>


<TR valign="bottom">
    <TD align="center" nowrap valign="top">/s/ GARY D. HENLEY
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
Gary D. Henley</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
President and Chief Executive Officer<BR>
(Principal Executive Officer) and Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">June 22, 2010</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">/s/ LANCE A. BERRY
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
Lance A. Berry</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Senior Vice President and Chief Financial
Officer<BR>
(Principal Financial Officer and
Principal Accounting Officer)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">June 22, 2010</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">/s/ DAVID D. STEVENS
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
David D. Stevens</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Chairman of the Board
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">June 22, 2010</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">/s/ GARY D. BLACKFORD
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
Gary D. Blackford</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">June 22, 2010</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">/s/ MARTIN J. EMERSON
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
Martin J. Emerson</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">June 22, 2010</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->5<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="40%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>

</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">Signature</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">Title</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">Date</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">/s/ LAWRENCE W. HAMILTON
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
Lawrence W. Hamilton</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">June 22, 2010</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">/s/ JOHN L. MICLOT
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
John L. Miclot</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">June 22, 2010</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">/s/ AMY S. PAUL
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
Amy S. Paul</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">June 22, 2010</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">/s/ ROBERT J. QUILLINAN
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
Robert J. Quillinan</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">June 22, 2010</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->6<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- link1 "INDEX TO EXHIBITS" -->
<DIV align="left"><A NAME="011"></A></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>INDEX TO EXHIBITS</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="90%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Exhibit No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Description of Exhibits</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Fourth Amended and Restated Certificate of Incorporation of Wright Medical Group,
Inc., <SUP style="font-size: 85%; vertical-align: text-top">(1)</SUP> as amended by Certificate of Amendment of Fourth Amended and
Restated Certificate of Incorporation of Wright Medical Group, Inc.<SUP style="font-size: 85%; vertical-align: text-top">(2)</SUP></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Second Amended and Restated Bylaws of Wright Medical Group, Inc. <SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.3
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amended and Restated 2009 Equity Incentive Plan.<SUP style="font-size: 85%; vertical-align: text-top"> (4)</SUP></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.4*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Inducement Stock Option Grant Agreement between the Registrant and Raymond C. Kolls
dated May&nbsp;31, 2010.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">5*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Opinion of Baker, Donelson, Bearman, Caldwell &#038; Berkowitz, PC concerning the legality
of the securities being registered.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.1*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of KPMG LLP.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.2*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Baker, Donelson, Bearman, Caldwell &#038; Berkowitz, PC (included in Exhibit&nbsp;5).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">24*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Power of Attorney (reference is made to the signature page).</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<DIV align="left">
<DIV style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96"></TD>
</TR>

<TR valign="top">
    <TD nowrap align="left"><SUP style="font-size: 85%; vertical-align: text-top">*</SUP></TD>
    <TD>&nbsp;</TD>
    <TD>Filed herewith.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left"><SUP style="font-size: 85%; vertical-align: text-top">(1)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD>Incorporated by reference to the Registrant&#146;s Registration Statement on Form S-1
(Registration No.&nbsp;333-59732), as amended.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left"><SUP style="font-size: 85%; vertical-align: text-top">(2)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD>Incorporated by reference to the Registrant&#146;s Registration Statement on Form S-8
filed on May&nbsp;14, 2004.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left"><SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD>Incorporated by reference to the Registrant&#146;s current report on Form 8-K filed on
February&nbsp;19, 2008.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left"><SUP style="font-size: 85%; vertical-align: text-top">(4)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD>Incorporated by reference to the Registrant&#146;s Definitive Proxy Statement filed on
April&nbsp;15, 2010.</TD>
</TR>

</TABLE>






<P align="center" style="font-size: 10pt"><!-- Folio -->7<!-- /Folio -->
</DIV>

</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "g23815sv8.htm", "description": "FORM S-8", "secsgml_size_bytes": 59625}]
{"company-data": {"conformed-name": "WRIGHT MEDICAL GROUP INC", "cik": "0001137861", "assigned-sic": "3842", "irs-number": "134088127", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-167682", "film-number": "10910924"}, "business-address": {"street1": "5677 AIRLINE ROAD", "city": "ARLINGTON", "state": "TN", "zip": "38002", "phone": "9018679971"}}
sv8
Table of Contents
As
filed with the Securities and Exchange Commission on June 22, 2010
Registration No. 333-_____
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-8
REGISTRATION OF SECURITIES UNDER
THE SECURITIES ACT OF 1933
WRIGHT MEDICAL GROUP, INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction
of incorporation or organization)
13-4088127
(I.R.S. Employer
Identification No.)
5677 Airline Road
Arlington, Tennessee
(Address of Principal Executive Offices)
38002
(Zip Code)
Wright Medical Group, Inc.
Amended and Restated 2009 Equity Incentive Plan
and
Inducement Stock Option Award
(Full title of the plan)
Gary D. Henley
President and Chief Executive Officer
Wright Medical Group, Inc.
5677 Airline Road
Arlington, Tennessee 38002
(Name and address of agent for service)
(901) 867-9971
(Telephone number, including area code, of agent for service)
Copy to:
Beverly Sanders Gates
Baker, Donelson, Bearman, Caldwell & Berkowitz, PC
165 Madison Avenue, 20th Floor
Memphis, Tennessee 38103
(901) 526-2000
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated
filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large
accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the
Exchange Act.
Large accelerated filer
x
Accelerated filer
o
Non-accelerated filer
o
Smaller reporting company
o
Table of Contents
CALCULATION OF REGISTRATION FEE
Proposed
Proposed
Amount
Maximum
Maximum
Amount of
Title of Securities
to be
Offering Price
Aggregate
Registration
to be Registered
Registered
(1)
Per Share
Offering Price
Fee
Common Stock
700,000
$18.03
(2)
$12,621,000
(2)
$900
Common Stock
65,000
$16.43
(3)
$1,067,950
(3)
$77
1.
This Registration Statement covers 700,000 shares of common stock, $0.01 par value per
share (the "Common Stock"), of Wright Medical Group, Inc. issuable pursuant to the Wright
Medical Group, Inc. Amended and Restated 2009 Equity Incentive Plan (the "Plan"). The Plan
was amended and restated effective May 13, 2010 upon the approval of the Registrant's
stockholders to increase by 700,000 the number of shares of Common Stock available for
awards under the Plan. Under the Plan as amended and restated, the Registrant is authorized
to issue 1,450,000 shares of Common Stock plus the number of shares of Common Stock granted
under the Wright Medical Group, Inc. Fifth Amended and Restated 1999 Equity Incentive Plan,
as amended (the "1999 Equity Incentive Plan") that are not exercised or forfeited, lapsed
or expired, or otherwise terminate without delivery of any shares of any Common Stock
subject thereto, to the extent such Common Stock would otherwise again have been available
for issuance under the 1999 Equity Incentive Plan. In addition, this Registration Statement
includes 65,000 shares reserved for issuance pursuant to an Inducement Stock Option Grant
Agreement dated May 31, 2010 between the Registrant and Raymond C. Kolls, Senior Vice
President, General Counsel and Secretary, approved by the Compensation Committee of the
Board of Directors of the Registrant. In addition, this Registration Statement covers such
indeterminable number of additional shares of Common Stock as may hereafter be offered or
issued pursuant to the Plan and the Inducement Stock Option Grant Agreement to prevent
dilution resulting from stock splits or similar transactions effected without receipt of
consideration and pursuant to Rule 416(c) under the Securities Act of 1933, as amended (the
"Securities Act").
2.
These figures are estimated solely for the purpose of calculating the amount of the
registration fee. The registration fee has been calculated pursuant to paragraphs (c) and
(h) of Rule 457 under the Securities Act based upon the average of the high and low sales
prices of the Common Stock as reported by the Nasdaq Global Select
Market on June 18, 2010.
3.
These figures are estimated solely for the purpose of calculating the amount of the
registration fee. The registration fee has been calculated pursuant to paragraph (h) of
Rule 457 under the Securities Act based upon the price at which the options subject to the
Inducement Stock Option Grant Agreement may be exercised. The exercise price represents the
closing sale price of the Common Stock as reported by the Nasdaq Global Select Market on
May 28, 2010, the date prior to the grant.
TABLE OF CONTENTS
EXPLANATORY NOTE
PART I
PART II INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference
Item 4. Description of Securities
Item 5. Interests of Named Experts and Counsel
Item 6. Indemnification of Directors and Officers
Item 7. Exemption from Registration Claimed
Item 8. Exhibits
Item 9. Undertakings
SIGNATURES
INDEX TO EXHIBITS
EX-4.4
EX-5
EX-23.1
Table of Contents
EXPLANATORY NOTE
Pursuant to General Instruction E to Form S-8 under the Securities Act of 1933, as amended, with
respect to the registration of additional securities of the same class as other securities for
which registration statements on Form S-8 relating to the same employee benefit plans are
effective, Wright Medical Group, Inc. (the "Registrant") hereby incorporates herein the contents of
its earlier registration statement, including any amendments thereto (Registration No. 333-159227),
by this reference and hereby deems such contents to be a part hereof, except as otherwise updated
or modified in this filing.
This Registration Statement covers 700,000 additional shares of common stock, $0.01 par value per
share (the "Common Stock"), of the Registrant issuable pursuant to the Wright Medical Group, Inc.
Amended and Restated 2009 Equity Incentive Plan (the "Plan"). The Plan was amended and restated
effective May 13, 2010 upon the approval of the Registrant's stockholders to increase by 700,000
the number of shares of Common Stock available for awards under the Plan. The Plan was originally
approved by the Registrant's stockholders May 13, 2009. Prior to amending and restating the Plan,
the Registrant was authorized to grant equity based awards under the Plan for up to 750,000 shares
of Common Stock, plus the number of shares of Common Stock granted under the Wright Medical Group,
Inc. Fifth Amended and Restated 1999 Equity Incentive Plan, as amended (the "1999 Equity Incentive
Plan") that are not exercised or forfeited, lapsed or expired, or otherwise terminate without
delivery of any shares of any Common Stock subject thereto, to the extent such Common Stock would
otherwise again have been available for issuance under the 1999 Equity Incentive Plan.
In addition, this Registration Statement covers 65,000 shares of Common Stock issuable pursuant to
an Inducement Stock Option Grant Agreement effective May 31, 2010 between the Registrant and
Raymond C. Kolls, Senior Vice President, General Counsel and Secretary.
PART I
The documents containing the information specified in Part I on Form S-8 will be sent or given to
participants as specified in Rule 428(b)(1) of the Securities Act. Such documents are not required
to be, and are not, filed with the Securities and Exchange Commission (the "Commission") either as
part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule
424 of the Securities Act. These documents and the documents incorporated by reference into this
Registration Statement pursuant to Item 3 of Part II of this Registration Statement, taken
together, constitute a prospectus that meets the requirements of Section 10(a) of the Securities
Act.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3.
Incorporation of Documents by Reference.
The following documents filed by the Registrant with the Commission are incorporated by reference
into this Registration Statement:
1.
Annual report on Form 10-K for the year ended December 31, 2009, filed on February 22, 2010;
2.
Current report on Form 8-K filed on March 9, 2010;
3.
Current report on Form 8-K filed on March 25, 2010;
4.
Quarterly report on Form 10-Q for the quarter ended March 31, 2010, filed on May 5, 2010;
5.
Current report on Form 8-K filed on May 5, 2010;
6.
Current report on Form 8-K filed on May 18, 2010;
7.
Current report on Form 8-K filed on June 1, 2010;
1
Table of Contents
8.
The description of the Common Stock is set forth under the heading "Type of Equity-Based
Awards" in the Prospectus portion of Amendment No. 2 to the Registration Statement on Form S-1
(Registration No. 333-81618) filed with the Commission on February 28, 2002.
All documents subsequently filed by the Registrant with the Commission pursuant to Sections 13(a),
13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), prior
to the filing of a post-effective amendment which indicates that all the securities offered hereby
have been sold or which deregisters all securities then remaining unsold, shall be deemed to be
incorporated by reference in this Registration Statement and to be a part hereof from the date of
the filing of such documents with the Commission.
Item 4.
Description of Securities.
Not applicable.
Item 5.
Interests of Named Experts and Counsel.
Not applicable.
Item 6.
Indemnification of Directors and Officers.
Section 145 of the General Corporation Law of the State of Delaware ("GCL") provides for the
indemnification of officers and directors under certain circumstances against expenses incurred in
successfully defending against a claim and authorizes Delaware corporations to indemnify their
officers and directors under certain circumstances against expenses and liabilities incurred in
legal proceedings involving such persons because of their being or having been an officer or
director.
Section 102(b) of the GCL permits a corporation, by so providing in its certificate of
incorporation, to eliminate or limit a director's liability to the corporation and its stockholders
for monetary damages arising out of certain alleged breaches of their fiduciary duty. Section
102(b)(7) of the GCL provides that no such limitation of liability may affect a director's
liability with respect to any of the following: (i) breaches of the director's duty of loyalty to
the corporation or its stockholders; (ii) acts or omissions not made in good faith or which involve
intentional misconduct of knowing violations of law; (iii) liability for dividends paid or stock
repurchased or redeemed in violation of the GCL; or (iv) any transaction from which the director
derived an improper personal benefit. Section 102(b)(7) does not authorize any limitation on the
ability of the corporation or its stockholders to obtain injunctive relief, specific performance or
other equitable relief against directors.
The Registrant's Fourth Amended and Restated Certificate of Incorporation, as amended, provides
that the Registrant shall indemnify to the fullest extent authorized or permitted under and in
accordance with the laws of the State of Delaware any person who was or is a party or is threatened
to be made a party to any action, whether civil, criminal, administrative or investigative by
reason of the fact that he or she is or was a director, officer, or employee or agent of the
Registrant, or is or was serving at the request of the Registrant in a similar capacity or in any
other capacity with another corporation, partnership, joint venture, trust or other enterprise,
against expenses (including attorneys' fees), judgments, fines and amounts paid in settlement
actually and reasonably incurred by him or her in connection with such action if he or she acted in
good faith and in a manner he or she reasonably believed to be in or not opposed to the best
interests of the Registrant, and had no reasonable cause to believe his or her conduct was
unlawful. However, each director will continue to be subject to liability for any breach of the
director's duty of loyalty to the Registrant or the Registrant's stockholders and for acts or
omissions not in good faith or involving intentional misconduct or knowing violations of law or, if
in failing to act, the director shall have acted in a manner involving intentional misconduct or a
knowing violation of the law, or for any transaction in which the director derived an improper
personal benefit. Expenses incurred in defending a civil or criminal action shall (in the case of
any action involving a director of the Registrant) or may (in the case of any action involving an
officer, trustee, employee or agent) be paid by the Registrant in advance of the final disposition
of such action as authorized by the board of directors upon receipt of an undertaking by or on
behalf of the indemnified person to repay such amount if it shall ultimately be determined that he
or she is not entitled to be indemnified by the Registrant.
2
Table of Contents
The Registrant's Second Amended and Restated Bylaws provide that the Registrant will indemnify any
and all of the Registrant's directors and officers, including former directors and officers,
including those serving as officer or director of any corporation at the request of the Registrant,
to the fullest extent permitted under and in accordance with the laws of the State of Delaware.
The Registrant has entered into an indemnification agreement with each of its directors and
officers that provides for the indemnification of such director or officer to the fullest extent
permitted by law for certain liabilities that arise by reason of the indemnitee's status as a
director, officer, employee, or agent of the Registrant or its affiliates. The indemnification
agreement provides that an indemnitee may be entitled to advancement of the expenses related to an
indemnifiable event and that the Registrant will cause the indemnitee to be covered by its general
liability insurance policy if the Registrant maintains such a policy. The rights of the indemnitee
under the indemnification agreement are in addition to any other rights that indemnitee may have
under the GCL, the Registrant's Fourth Amended and Restated Certificate of Incorporation, as
amended, and the Registrant's Second Amended and Restated Bylaws.
The Registrant maintains a general liability insurance policy that covers certain liabilities of
directors and officers of the Registrant and its affiliates arising out of claims based on acts or
omissions in their capacities as directors or officers.
Item 7.
Exemption from Registration Claimed.
Not applicable.
Item 8.
Exhibits.
The following exhibits are filed as part of this Registration Statement:
Exhibit No.
Description of Exhibits
4.1
Fourth Amended and Restated Certificate of Incorporation of Wright Medical Group,
Inc.,
(1)
as amended by Certificate of Amendment of Fourth Amended and
Restated Certificate of Incorporation of Wright Medical Group, Inc.
(2)
4.2
Second Amended and Restated Bylaws of Wright Medical Group, Inc.
(3)
4.3
Amended and Restated 2009 Equity Incentive Plan.
(4)
4.4*
Inducement Stock Option Grant Agreement between the Registrant and Raymond C. Kolls
dated May 31, 2010.
5*
Opinion of Baker, Donelson, Bearman, Caldwell & Berkowitz, PC concerning the legality
of the securities being registered.
23.1*
Consent of KPMG LLP.
23.2*
Consent of Baker, Donelson, Bearman, Caldwell & Berkowitz, PC (included in Exhibit 5).
24*
Power of Attorney (reference is made to the signature page).
*
Filed herewith.
(1)
Incorporated by reference to the Registrant's Registration Statement on Form S-1
(Registration No. 333-59732), as amended.
3
Table of Contents
(2)
Incorporated by reference to the Registrant's Registration Statement on Form S-8
filed on May 14, 2004.
(3)
Incorporated by reference to the Registrant's current report on Form 8-K filed on
February 19, 2008.
(4)
Incorporated by reference to the Registrant's Definitive Proxy Statement filed on
April 15, 2010.
Item 9.
Undertakings.
(a) The undersigned Registrant hereby undertakes:
(1) To file, during any period in which offers or sales are being made, a post-effective
amendment to this Registration Statement:
(i) To include any prospectus required by Section 10(a)(3) of the Securities Act;
(ii) To reflect in the prospectus any facts or events arising after the effective date
of this Registration Statement (or the most recent post-effective amendment thereof) which,
individually or in the aggregate, represent a fundamental change in the information set
forth in this Registration Statement. Notwithstanding the foregoing, any increase or
decrease in volume of securities offered (if the total dollar value of securities offered
would not exceed that which was registered) and any deviation from the low or high end of
the estimated maximum offering range may be reflected in the form of prospectus filed with
the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price
represent no more than 20 percent change in the maximum aggregate offering price set forth
in the "Calculation of Registration Fee" table in the effective Registration Statement; and
(iii) To include any material information with respect to the plan of distribution not
previously disclosed in this Registration Statement or any material change to such
information in the Registration Statement.
Provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information
required to be included in a post-effective amendment by those paragraphs is contained in periodic
reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or
Section 15(d) of the Exchange Act that are incorporated by reference in this Registration
Statement.
(2) That, for the purpose of determining any liability under the Securities Act, each such
post-effective amendment shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof.
(3) To remove from registration by means of a post-effective amendment any of the securities
being registered which remain unsold at the termination of the offering.
The undersigned Registrant hereby undertakes that, for purposes of determining any liability under
the Securities Act, each filing of the Registrant's annual report pursuant to Section 13(a) or
Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan's
annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in
this Registration Statement shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof.
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to
directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions,
or otherwise, the Registrant has been advised that in the opinion of the Commission such
indemnification is against public policy as expressed in the Securities Act and is, therefore,
unenforceable. In the event that a claim for indemnification against such liabilities (other than
the payment by the Registrant of expenses incurred or paid by a director, officer, or controlling
person of the Registrant in the successful defense of any action, suit or proceeding) is asserted
by such director, officer or controlling person in connection with the securities being registered,
the Registrant will, unless in the opinion of its counsel the matter has been settled by
controlling precedent, submit to a court of appropriate jurisdiction the
question whether such indemnification by it is against public policy as expressed in the Securities
Act and will be governed by the final adjudication of such issue.
4
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has
reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has
duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of Arlington, State of Tennessee, on
June 22, 2010.
WRIGHT MEDICAL GROUP, INC.
By:
/s/ Gary D. Henley
Gary D. Henley
President and Chief Executive Officer
POWER OF ATTORNEY
Each of the undersigned directors and officers of Wright Medical Group, Inc. hereby severally
constitutes and appoints Raymond C. Kolls and Lance A. Berry, and each of them, as the
attorneys-in-fact for the undersigned, in any and all capacities, with full power of substitution,
to sign any and all pre- or post-effective amendments to this Registration Statement, any
subsequent registration statement for the same offering which may be filed pursuant to Rule 462(b)
under the Securities Act of 1933, as amended, and any and all pre- or post-effective amendments
thereto, and to file the same with exhibits thereto and other documents in connection therewith,
with the Securities and Exchange Commission, granting unto said attorneys-in-fact full power and
authority to do and perform each and every act and thing requisite and necessary to be done in and
about the premises, as fully to all intents and purposes as he might or could do in person, hereby
ratifying and confirming all that said attorney-in-fact may lawfully do or cause to be done by
virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement
has been signed by the following persons in the capacities and on the dates indicated:
Signature
Title
Date
/s/ GARY D. HENLEY
Gary D. Henley
President and Chief Executive Officer
(Principal Executive Officer) and Director
June 22, 2010
/s/ LANCE A. BERRY
Lance A. Berry
Senior Vice President and Chief Financial
Officer
(Principal Financial Officer and
Principal Accounting Officer)
June 22, 2010
/s/ DAVID D. STEVENS
David D. Stevens
Chairman of the Board
June 22, 2010
/s/ GARY D. BLACKFORD
Gary D. Blackford
Director
June 22, 2010
/s/ MARTIN J. EMERSON
Martin J. Emerson
Director
June 22, 2010
5
Table of Contents
Signature
Title
Date
/s/ LAWRENCE W. HAMILTON
Lawrence W. Hamilton
Director
June 22, 2010
/s/ JOHN L. MICLOT
John L. Miclot
Director
June 22, 2010
/s/ AMY S. PAUL
Amy S. Paul
Director
June 22, 2010
/s/ ROBERT J. QUILLINAN
Robert J. Quillinan
Director
June 22, 2010
6
Table of Contents
INDEX TO EXHIBITS
Exhibit No.
Description of Exhibits
4.1
Fourth Amended and Restated Certificate of Incorporation of Wright Medical Group,
Inc.,
(1)
as amended by Certificate of Amendment of Fourth Amended and
Restated Certificate of Incorporation of Wright Medical Group, Inc.
(2)
4.2
Second Amended and Restated Bylaws of Wright Medical Group, Inc.
(3)
4.3
Amended and Restated 2009 Equity Incentive Plan.
(4)
4.4*
Inducement Stock Option Grant Agreement between the Registrant and Raymond C. Kolls
dated May 31, 2010.
5*
Opinion of Baker, Donelson, Bearman, Caldwell & Berkowitz, PC concerning the legality
of the securities being registered.
23.1*
Consent of KPMG LLP.
23.2*
Consent of Baker, Donelson, Bearman, Caldwell & Berkowitz, PC (included in Exhibit 5).
24*
Power of Attorney (reference is made to the signature page).
*
Filed herewith.
(1)
Incorporated by reference to the Registrant's Registration Statement on Form S-1
(Registration No. 333-59732), as amended.
(2)
Incorporated by reference to the Registrant's Registration Statement on Form S-8
filed on May 14, 2004.
(3)
Incorporated by reference to the Registrant's current report on Form 8-K filed on
February 19, 2008.
(4)
Incorporated by reference to the Registrant's Definitive Proxy Statement filed on
April 15, 2010.
7